Autolus Therapeutics PLC (NAS:AUTL)
$ 3.815 -0.025 (-0.65%) Market Cap: 1.01 Bil Enterprise Value: 314.39 Mil PE Ratio: 0 PB Ratio: 1.74 GF Score: 55/100

Q4 2018 Autolus Therapeutics PLC Earnings Call Transcript

Feb 25, 2019 / 01:00PM GMT
Operator

Good day, and welcome to the Autolus Therapeutics Financial Results Conference Call. (Operator Instructions)

Please note, this event is being recorded.

I would now like to turn the conference over to Silvia Taylor, Vice President of Corporate Affairs and Communications. Please go ahead.

Silvia Taylor

Thanks, Andrew. Good morning, and good afternoon, everyone, and thank you for taking part in today's call. With me today are Christian Itin, Chairman and Chief Executive Officer; and Andrew Oakley, Chief Financial Officer. Also, Christopher Vann, Chief Operating Officer; and Vijay Reddy, Chief Medical Officer, will join us for the Q&A portion of our call.

Before we begin, I would like to remind you that during this call, we will be making forward-looking statements. All statements, other than the statements of historical fact contained in this presentation, are forward-looking statements. Our actual results, performance or achievements may be materially different from those expressed or implied by the forward-looking statements. For a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot